Modon Holding posts AED 2.1bn net profit in H1 2025    Egypt's Electricity Ministry says new power cable for Giza area operational    Egypt exports first high-tech potato seeds to Uzbekistan after opening market    Egypt's Al-Sisi, Italian defence minister discuss Gaza, security cooperation    Egypt's FM discusses Gaza, Nile dam with US senators    Aid airdrops intensify as famine deepens in Gaza amid mounting international criticism    Health minister showcases AI's impact on healthcare at Huawei Cloud Summit    On anti-trafficking day, Egypt's PM calls fight a 'moral and humanitarian duty'    Federal Reserve maintains interest rates    Egypt strengthens healthcare partnerships to enhance maternity, multiple sclerosis, and stroke care    Egypt keeps Gaza aid flowing, total tops 533,000 tons: minister    Indian Embassy to launch cultural festival in Assiut, film fest in Cairo    Egyptian aid convoy heads toward Gaza as humanitarian crisis deepens    Culture minister launches national plan to revive film industry, modernise cinematic assets    Sudan's ambassador to Egypt holds reconstruction talks on with Arab League    I won't trade my identity to please market: Douzi    Sisi calls for boosting oil & gas investment to ease import burden    Egypt welcomes 25-nation statement urging end to Gaza war    Sisi sends letter to Nigerian president affirming strategic ties    Egypt, Senegal sign pharma MoU to unify regulatory standards    Two militants killed in foiled plot to revive 'Hasm' operations: Interior ministry    Egypt, Somalia discuss closer environmental cooperation    58 days that exposed IMF's contradictions on Egypt    Egypt's EHA, Huawei discuss enhanced digital health    Foreign, housing ministers discuss Egypt's role in African development push    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FDA authorises IQOS marketing as modified risk tobacco product
Decision ensures users can make informed switch to IQOS as better choice to smoking
Published in Daily News Egypt on 13 - 07 - 2020

The US Food and Drug Administration (FDA) authorised, on Sunday, the marketing of the IQOS, Philip Morris International's (PMI) electrically heated tobacco device, as a modified risk tobacco product (MRTP).
In doing so, the agency noted that an IQOS exposure modification order is appropriate in promoting public health.
The decision demonstrates that IQOS is a different product to standard tobacco, and a better choice for adults who would otherwise continue smoking. The device is the first and only electronic nicotine product to be granted marketing orders through the FDA's MRTP process
The FDA authorised marketing of IQOS devices as a unit that heats tobacco but does not burn it. With this heating system in place, the production of harmful and potentially harmful chemicals are significantly reduced.
Scientific studies have shown that switching completely from conventional cigarettes to an IQOS device reduces the human body's exposure to harmful or potentially harmful chemicals.
The agency concluded that the available scientific evidence demonstrates that IQOS devices are expected to provide reduced health impairments in comparison to standard cigarettes. This takes into account both users of tobacco products and those who do not currently use them.
The FDA's decision further builds on the emerging independent international scientific consensus that IQOS devices are a better choice than continuing to smoke standard cigarettes. It also follows the agency's April 2019 decision authorising for IQOS devices to be sold in the US.
Additionally, the FDA's decision is an important example of how governments and public health organisations can regulate smoke-free alternatives to differentiate them from cigarettes to ensure greater health protections.
The decision follows a review of the extensive scientific evidence package PMI submitted to the FDA in December 2016 to support its MRTP applications.
"The decision makes it possible to inform adults that switching completely to IQOS is a better choice than continuing to smoke," PMI CEO André Calantzopoulos said, "The FDA determined that scientific studies show that switching completely from conventional cigarettes to IQOS reduces exposure to harmful or potentially harmful chemicals."
Calantzopoulos added that IQOS is a different product to combustible cigarettes and must be regulated differently, as the FDA has recognised. The decision reflects the urgent need for a different, cooperative approach to achieve a smoke-free future.
"We are excited that this important decision will help guide the choices of adult smokers in the US, and that the best health choice is to never start smoking or to quit altogether," Calantzopoulos said, "For those who don't quit, the best thing they can do is switch to a scientifically substantiated smoke-free product."
He added that PMI estimates that, as of 31 March, statistics show approximately 10.6 million adult smokers worldwide have already stopped smoking and switched to IQOS.
"We believe that this decision can help to further accelerate the transition of US adults away from cigarettes" Calantzopoulos said, "We, along with our licensee Altria, are committed to guarding against unintended use and fully support FDA's focus on protecting youth."
"Moreover, the decision is a result of our ongoing commitment to put science at the forefront as we continue on our quest to replace cigarettes with smoke-free alternatives as quickly as possible," he added.
Vassilis Gkatzelis, Managing Director of Philip Morris Egypt & Levant said, "This is a historic milestone. The FDA reviewed all available science and confirmed that IQOS is distinctly different from cigarettes, because it has been demonstrated to reduce exposure to harmful chemicals. Now is the time to rapidly shift adult smokers away from cigarettes. Scientifically substantiated better alternatives like IQOS represent a public health opportunity."
Philip Morris International (PMI) is leading a transformation in the tobacco industry, to ultimately replace cigarettes with smoke-free products and create a smoke-free future. It looks to create products that benefit adults who would otherwise continue to smoke.


Clic here to read the story from its source.